It is vital for biotech companies to run the right clinical trial and not cut costs, the Sanofi executive said.

BioVaxys Technology and Sona Nanotech have signed an agreement to develop cancer therapeutics, utilising the DPX platform ...

The Vivo Opportunity Fund has already catalysed a plethora of medicine development via biotech investments in its first two ...

ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the United States.

Viralgen has partnered biotech company Trogenix, aiming to accelerate the development of gene therapy for glioblastoma.